This is a preview of subscription content, log in via an institution to check access.
References
T. G. Pukhal'skaya, N. I. Maysov, and R. S. Mirsoyan,Farmakol. Toksikol. No 6, 39–43 (1989).
M. Anthony, H. Hinterberger, and J. W. Lance,Arch. Neurol. (Chicago),16, 544–552 (1967).
J. L. Costa, D. L. Murphy, and H. Stark,J. Physiol. (London),316, 153–161 (1981).
D. A. Curran, H. Hinterberger, and J. W. Lance,Brain,88, 997–1010 (1965).
E. Hanington, R. J. Jones, J. A. J. Agmess, and B. Wachowicz,Lancet,2, 720–723 (1981).
O. Lingjarde and P. Monstad,Cephalalgia,6, 135–139 (1986).
M. C. Michel, A. Rother, C. Hiemke, and R. Ghraf,Biochem. Pharmacol.,36, 3175–3180 (1987).
M. Rehavi, H. Sepcuti, and A. Weizman,Brain Res.,410, 135–139 (1987).
F. Sicuteri, A. Testi, and B. Anselmi,Int. Arch. Allergy Appl. Immunol.,19, 55–58 (1961).
J. M. Sneddon, in:Progress in Neurobiology (G.A. Kerkut and A. Phillis, eds), Vol. 1, Pergamon Press, Oxford (1973), pp. 151–198.
S. M. Stahl, in:The Platelets: Physiology and Pharmacology (G. L. Longenecker, ed.), Academic Press, New York (1985), pp. 307–340.
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol 115, No 6, pp. 609–612, June, 1993
Rights and permissions
About this article
Cite this article
Pukhal'skaya, T.G. Effects of steroid hormones and anti-migraine drugs on serotonin transport in platelets of patients suffering from migraine and in those of healthy subjects. Bull Exp Biol Med 115, 679–682 (1993). https://doi.org/10.1007/BF00791157
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00791157